U.S. FDA delays decision on Juul e-cigarettes

This post was originally published on this site

The agency had been expected to make a decision by Thursday, a year after Juul and other e-cigarette brands, including British American Tobacco (NYSE:BTI) Plc’s Vuse and Imperial Brands (OTC:IMBBY) Plc’s Blu, faced a deadline to file applications showing their products provided a net benefit to public health.

The agency said on Thursday that it continues to “work expeditiously on the remaining applications,” adding many are “in the final stages of review.”